Sorriso Pharmaceuticals
Salt Lake City, Utah, United States · Biopharma, Biotechnology, Health Care
Sorriso Pharmaceuticals is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including ulcerative colitis and Crohn’s disease. They are developing novel orally dosed antibodies that target critical pathways in conditions like inflammatory bowel disease. Their innovative approach aims to deliver effective therapies with m
Key facts
- Headquarters
- Salt Lake City, Utah, United States
- Employees
- 12
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- sorrisopharma.com
- Company page
Recent activity at Sorriso Pharmaceuticals
Leadership
- Susan Dubé, Chief Financial Officer
- Sara Barbat, Bsn, Rn
- Kevin Roberts, Senior Director of Research
- Jackie Benson, Chief Scientific Officer
- Mike Grey, Experienced Biotech CEO and Board Member
Verified email and direct lines for Sorriso Pharmaceuticals’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Sorriso Pharmaceuticals in the news
Companies similar to Sorriso Pharmaceuticals
- Jubilant Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Ensho Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Lighthouse Pharmaceuticals · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- LTR Pharma Limited · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Verdiva Bio · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About Sorriso Pharmaceuticals: questions and answers
What does Sorriso Pharmaceuticals do?
Sorriso Pharmaceuticals is a biopharmaceutical company advancing a pipeline of disease-modifying antibodies for the treatment of immune-mediated diseases, including ulcerative colitis and Crohn’s disease. They are developing novel orally dosed antibodies that target critical pathways in conditions like inflammatory bowel disease. Their innovative approach aims to deliver effective therapies with m
Where is Sorriso Pharmaceuticals headquartered?
Sorriso Pharmaceuticals is headquartered in Salt Lake City, Utah, United States.
How many employees does Sorriso Pharmaceuticals have?
Sorriso Pharmaceuticals has about 12 employees.
Who leads Sorriso Pharmaceuticals?
Mike Grey is an Experienced Biotech CEO and Board Member at Sorriso Pharmaceuticals.
What is the latest news on Sorriso Pharmaceuticals?
On Dec 19, 2024, Sorriso Pharmaceuticals Announces Positive Phase 1b Results for SOR102 to Treat Ulcerative Colitis.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy